These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hematologic therapy of malignant lymphoma]. Honetz N Wien Klin Wochenschr; 1971 Jul; 83(27):522-3. PubMed ID: 5123479 [No Abstract] [Full Text] [Related]
9. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case. Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785 [TBL] [Abstract][Full Text] [Related]
10. [Controversies in therapy of malignant lymphomas]. Diehl V; Engert A Internist (Berl); 1994 Apr; 35(4):313-22. PubMed ID: 8200756 [No Abstract] [Full Text] [Related]
11. [High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma]. Tobinai K Gan To Kagaku Ryoho; 1995 Oct; 22(12):1724-30. PubMed ID: 7574802 [TBL] [Abstract][Full Text] [Related]
12. Malignant lymphoma: an update on diagnosis, staging, and management. Perlin E Prim Care; 1980 Sep; 7(3):409-22. PubMed ID: 6905202 [TBL] [Abstract][Full Text] [Related]
13. [Long-term therapy in leukemias and malignant lymphomas]. Aul C; Schneider W Fortschr Med; 1983 Feb; 101(7):275-82. PubMed ID: 6840654 [No Abstract] [Full Text] [Related]
15. [Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions]. INTROZZI P; MARINONE G Haematologica; 1953; 37(11):1195-1274. PubMed ID: 13151517 [No Abstract] [Full Text] [Related]
16. [Malignant lymphoma]. Streuli RA Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304 [No Abstract] [Full Text] [Related]
17. [Malignant lymphoma of the neck, nose and pharyngeal region]. Cerny T Schweiz Rundsch Med Prax; 1993 Dec; 82(50):1447-51. PubMed ID: 8290837 [TBL] [Abstract][Full Text] [Related]
18. Care of the patient with malignant lymphoma. Hays K; Rafferty DC Nurs Clin North Am; 1982 Dec; 17(4):677-95. PubMed ID: 6817308 [No Abstract] [Full Text] [Related]
19. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]